Taxotere

Links shared publicly online about this topic

Generic Taxotere Gets FDA Marketing Okay

breastcancer.org — “Generic Taxotere Gets FDA Marketing OkayView full resource at breastcancer.org

  • View Related
  • Share

Most Recently Shared on March 21, 2011 at 11:58 am By:

jodyms Jody Schoger Patient Expert

Good for the medical bills - BC survivors - generic form of Taxotere approved by FDA http://bit.ly/hOI5HF #wcancer #bcsm

11 months ago...

Mylan pulls EU application for generic Taxotere | Reuters

reuters.com — “LONDON, March 15 (Reuters) - Mylan has withdrawn its application to market a generic version of Sanofi-Aventis's cancer drug in Europe, after adverse feedback from regulators.View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 12:58 pm By:

FiercePharma FiercePharma Health Site

Reuters: Mylan pulls EU application for generic #Taxotere. http://bit.ly/a0UhNE

2 years ago...

Single vial formulation of Taxotere approved - ONA

oncologynurseadvisor.com — “Sanofi-aventis announced that the FDA has approved a one-vial formulation of Taxotere (docetaxel injection concentrate).View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on August 5, 2010 at 2:55 pm By:

Single vial formulation of Taxotere approved - MPR

empr.com — “Sanofi-aventis announced that the FDA has approved a one-vial formulation of Taxotere (docetaxel injection concentrate).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 5, 2010 at 3:20 pm By:

eMPR MPR Medical Publisher

MPR News: Single vial formulation of Taxotere approved: Sanofi-aventis announced that the FDA has approved a one-v... http://bit.ly/ceoMsH

2 years ago...

Neoadjuvant Taxotere and ADT Well Tolerated in High-risk Prostate Cancer

professional.cancerconsultants.com — “Neoadjuvant Taxotere and ADT Well Tolerated in High-risk Prostate CancerView full resource at professional.cancerconsultants.com

  • View Related
  • Share

Most Recently Shared on October 27, 2009 at 8:51 pm By:

prostatecancer_ Prostate Cancer Support

Neoadjuvant Taxotere® and ADT Well Tolerated in High-risk Prostate Cancer http://bit.ly/4nvNC3

2 years ago...

Dad starting chemo-advice on taxotere? | Cancer Survivors Network

csn.cancer.org — “Dad starting chemo-advice on taxotere? | Cancer Survivors NetworkView full resource at csn.cancer.org

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 4:56 pm By:

prostatediaries john clay mchugh Surgeon, Urologist, Physician, and Doctor

Dad starting chemo-advice on taxotere?: My dad is 65 and has prostate cancer that has spread to his bones. Lupron ... http://bit.ly/dv9lhO

1 year ago...

Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of Taxotere

professional.cancerconsultants.com — “Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of TaxotereView full resource at professional.cancerconsultants.com

  • View Related
  • Share

Most Recently Shared on March 5, 2010 at 3:38 pm By:

prostatecancer_ Prostate Cancer Support

Cabazitaxel Effective for Hormone Refractory Prostate Cancer After Failure of ... http://bit.ly/asi3l0

2 years ago...

Medical News: Generic Taxotere Gets FDA Marketing Okay - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved marketing of generic docetaxel -- previously under patent and sold as Taxotere by sanofi-aventis.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 11, 2011 at 6:29 pm By:

UPDATE 1-U.S. court invalidates Sanofi's Taxotere patents | Reuters

reuters.com — “* Ruling invalidates two patents * Clears the way for generic competition by year-end (Adds Sanofi comment in paragraph six, updates stock prices) By Tom Hals WILMINGTON, Del., Sept 28 (Reuters)View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 28, 2010 at 7:55 pm By:

FiercePharma FiercePharma Health Site

Reuters: U.S. court invalidates Sanofi's Taxotere patents. http://bit.ly/9U3FGS

1 year ago...

Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE CANCER INFOLINK

prostatecancerinfolink.net — “Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE CANCER INFOLINKView full resource at prostatecancerinfolink.net

  • View Related
  • Share

Most Recently Shared on November 11, 2009 at 9:05 pm By:

prostatecancer_ Prostate Cancer Support

Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE ... http://bit.ly/AbW5u

2 years ago...

UPDATE 2-US FDA cites Sanofi on breast cancer drug marketing | Reuters

reuters.com — “* FDA says journal reprint is misleading * Materials overstated Taxotere's benefits -FDA * Sanofi: materials appropriate, working with FDA (Adds company comment, paragraphs 6-7) WASHINGTON, MayView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 14, 2009 at 2:02 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

FDA cites Sanofi on breast cancer drug marketing http://twurl.nl/n7jjg0

3 years ago...

Proteomics Study Reveals A Protein That, When Suppressed, Makes Cancers More Susceptible To Chemotherapy

medicalnewstoday.com — “Taxanes, a group of cancer drugs that includes paclitaxel (taxol®) and docetaxel (taxotere®), have become front-line therapy for a variety of metastatic cancers. but as with many chemotherView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 28, 2010 at 1:14 pm By:

mnt_cancer MNT Cancer News Health News

Proteomics Study Reveals A Protein That, When Suppressed, Makes Cancers More Susceptible To Chemotherapy http://mnt.to/3wRc #cancer

2 years ago...

ResearchPoint & Azaya Therapeutics Announce First Patient Enrolled In Phase I Clinical Study

medicalnewstoday.com — “Researchpoint and azaya therapeutics, inc. are proud to announce the study initiation and enrollment of the first patient in the phase i clinical study of ati-1123, a new formulation of docetaxel.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 28, 2010 at 9:37 am By:

medical_tweets medical_tweets Health News

ResearchPoint & Azaya Therapeutics Announce First Patient Enrolled In Phase I Clinical Study ResearchPoint and Azaya .. http://bit.ly/9CWUxF

2 years ago...

Hospira generic of Sanofi cancer drug approved | Reuters

reuters.com — “NEW YORK (Reuters) - Hospira Inc won approval for the first U.S. generic version of Sanofi-Aventis SA's big-selling Taxotere cancer drug, sending Hospira shares up 2 percent.U.S. sales of Taxotere, anView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 9, 2011 at 5:29 pm By:

Hospira gets approval for generic of Sanofi cancer drug | Reuters

reuters.com — “NEW YORK (Reuters) - Hospira Inc won approval for the first U.S. generic version of Sanofi-Aventis SA's big-selling Taxotere cancer drug, sending Hospira shares up 2.5 percent.U.S. sales of Taxotere,View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 9, 2011 at 4:19 pm By:

Reuters_Health Reuters Health Health News

Hospira gets approval for generic of Sanofi cancer drug http://reut.rs/hQ2FuK

11 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • jodyms

    Jody Schoger

    Free-lance writer, cancer survivor & advocate, cyclist, quilter, art lover and reader. Have dog, we travel.

    View Profile

  • FiercePharma

    FiercePharma

    FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com

    View Profile

  • ONAcom

    OncologyNurseAdvisor

    Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390